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Vievvpoint 
A Nevv Phase of Development 
The opening of the John D. Rockefeller, Jr. and David Rockefeller Research 
Building marks a new phase in the development of this university and cam­
pus. The 100,000 square feet of new laboratory space inside this $90 million 
dollar, state-of-the-art building will enable us to recrult new junior and 
senior faculty, and free up facilities for scientists working on other parts of 
the campus who for years have needed additional research space. 
To celebrate the opening of this marvelous new facility, we invited repre­
sentatives from many worlds-govern�ent, business, science, and culture. 
For this day of dedication and the three festive days that followed it, we tried 
to take as much of the ivory out of our tower as possible. We organized 
exhibits, tours, and lectures for friends of The Rockefeller University, for the 
surrounding community, and for individuals in all parts of this university, to 
demonstrate our desire to be linked more closely with the diverse worlds of 
this great city. 
For all the astounding intellectual and technical advances of recent years, the scientists of this campus's 
past would find much that is familiar in the laboratories this building will house-labs devoted to cell biology 
and immunology, to molecular and structural biology-all fields that the university helped pioneer. And 
I am certain that they also would find familiar the continuing commitment of the Rockefeller family to this 
university. But they might be surprised by another name that helped make this building possible-that of 
Howard Hughes. The Howard Hughes Medical Institute has quite literally provided the foundation for our 
new facility, and will continue to support the Howard Hughes senior and junior investigators working on 
four of its floors. 
The similarity between the Howard Hughes Medical Institute and The Rockefeller University transcends 
the parallel use of private fortunes for the public good. Both share a philosophy that strikes at the heart of the 
whole scientific enterprise: Find the most talented researchers possible, and then give them the facilities and the 
freedom to pursue their studies wherever they might lead. For like novelists being surprised when one of their 
characters takes on a life of its own-performing actions that were not planned, not part of the plot-we scien­
tists are constantly being overtaken by surprises as we work in our laboratories. We try to make a cell do one 
thing, and instead it keeps doing another, until we are forced to ask: Why is it doing that? And then, this new 
question asked, we are off performing a series of experiments we could hardly have anticipated a week ago. 
The current debate in Washington on how best to balance support for basic and applied research is in some 
ways misleading: the two interpenetrate. The history of science at Rockefeller and other research institutions 
powerfully attests that it is the asking of basic questions about the operations of nature, pursued by investigators 
working alone or in small groups, that largely provides the foundations for novel clinical and industrial applica­
tions. Science is a creative activity rooted in the independence of the individual researcher, and respect for this 
intellectual freedom must continue to be at the core of government support for science. 
Yet in times of scarce resources, we in the scientific community recognize that more must be done to enable 
the fruits of our discoveries to blossom into economically and medically useful technologies and treatments. 
Whether our t9wers are made of ivory, or of glass, steel, and stone, they must have doors that lead out as well 
as in. Let us hope they lead out to more open-air symposia like the one that occurred at the opening of our new 
research facility, when the worlds of government, business, science and culture came together and freely dis­
cussed how our common interests may best be served. 
T orsten Wiesel 
President. The Rockefeller University 
The Shape of Nature 
X-ray crystallography and nuclear magnetic resonance
spectroscopy reveal the 3-D structure of molecules
In the course of its lifetime, a cell 
receives countless messages to grow, 
divide, .ind differentiate. Properly 
communicated, these messages pro­
mote the normal development and 
healthy functioning of the organism 
Among biology's 
most compelling (and 
competitive) efforts 
is the search to 
unravel the intrica-
cies of the cellular 
signaling netvvork. 
Recently, tvvo 
Rockefeller research 
groups advanced 
this endeavor signifi­
cantly by providing 
important nevv 
information about a 
crucial element in the 
signaling matrix. 
to which the cell be-
longs. But if the commu­
nication goes awry, dis­
aster can ensue. 
Among biology's most 
compelling (and com­
petitive) efforts is the 
search to unravel the 
intricacies of the cellular 
signaling network. Re­
cently, two Rockefeller 
research groups ad­
vanced this endeavor sig­
nificantly by providing 
important new informa­
tion about a crucial ele­
ment in the signaling 
matrix. Each group start­
ed work independently, 
using their own special­
ized research techniques. 
But their efforts were 
facilitated by Rocke­
feller's historic areas of 
scientific inquiry, and by 
the unique opportunities for com­
munication that the university's 
structure provides. 
In a hotly contested field, the 
Rockefeller researchers provided the 
first views of the three-dimensional 
structure of protein regions called 
SH2 domains. A protein "domain" 
is a protein segment that performs a 
particular function. An individual 
protein may contain many different 
domains with different functions. 
The role of SH2 domains, found in 
a large number of proteins, is to 
serve as "readers" for messages sent 
through the cell in response to sig­
nals that reach its surface. 
Susan Blum is a science writer in The 
Rockefeller University Public Affairs Office. 
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"To send a signal, you need 
something that acts as a switch, like 
a green or red light," explains John 
Kuriyan, who led one of the multi­
lab groups involved in the research. 
There are several kinds of molecular 
switches, one of the most important 
of which is a phenomenon known as 
tyrosine phosphorylation. This is a 
process that p�ts a highly charged 
substance called phosphate on tyro­
sine, one of the twenty amino acids 
used as the building blocks for all 
proteins. The specific pattern of 
tyrosine phosphorylation varies for 
each different protein that can serve 
as a molecular switch. 
TRIPPING THE 
MOLECULAR SWITCH 
SH2 domains bind to phosphorylat­
ed tyrosines, thereby registering that 
the molecular switch has been 
tripped. The protein in which the 
SH2 domain is embedded then 
helps pass the cellular signal along. 
"SH2 domains are vitally important 
in regulating cell differentiation, 
growth, and division," says David 
Cowburn, the leader of the other 
multi-lab team. "The aberrant cell 
differentiation that leads to birth 
defects and the uncontrolled cell 
growth that is a hallmark of cancer 
frequently result from the break­
down of switching mechanisms 
directly involved with these 
domains." Indeed, many oncogenes, 
or cancer genes, are genes whose 
normal function is to c�de for pro­
teins containing SH2 domains. 
When these genes are mutated, the 
messages they transmit are scram­
bled in ways that can contribute 
to cancer. 
Before the work of the two 
Rockefeller groups was published 
simultaneously last summer, scien-
by Susan Blum 
tists had already determined the 
order in which the amino acids of 
SH2 domains are linked together 
like beads on a chain. But this 
knowledge, though useful, gave no 
hint about how the domains actually 
accomplish their cellular tasks. To 
know how any protein functions, 
researchers must also know its 3-D 
structure-the characteristic confor­
mation of twists, pockets, and pro­
jections that endows it with exactly 
the right combination of chemical, 
mechanical, and electrostatic forces 
to get the job done. Thus, by pro­
viding the first 3-D views of two dif­
ferent SH2 domains, the Rockefeller 
researchers inaugurated a new phase 
in the understanding of the cellular 
signaling network. (A third group, 
from Oxford a11d London U niver­
si ties, reported the structure of 
another SH2 domain at the same 
time.) 
The team headed by Cowburn 
revealed the structure of the SH2 
domain of a protein called abl (pro­
nounced "able.") The gene that 
codes for this protein-a gene that 
is involved in leukemia-is under 
intensive study in the laboratory 
of Rockefeller Professor David 
Baltimore. Researchers in the 
Baltimore lab collaborated with the 
Cowburn group by supplying ample 
quantities of the abl protein's SH2 
domain. 
The domai? was the right size 
for investigation by the nuclear 
magnetic resonance (NMR) spec­
troscopy tech�iques. employed by 
members of the Cowburn lab. This 
method, which studies molecules as 
they float in solution, exploits the 
magnetic properties 6f atomic 
nuclei, revealing the distances 
between atoms and the "cross talk" 
they engage in (see "How does 
nuclear magnetic resonance spec­
troscopy work?", page 14 ). 
The group led by Kuriyan 
derived the structure of the SH2 
domain of a protein called src (pro­
nounced "sark"). The gene that 
codes for this protein has a long tra­
dition of study at Rockefeller dating 
back to 1911, when Peyton Rous 
isolated a virus that transmitted 
cancer among chickens. The virus' 
cancer-causing gene was later iden­
tified and named src. As one of the 
first cancer genes ever investigated, 
src is in many ways a reference point 
for researchers; in fact, the "SH" in 
the name SH2 stands for "src 
homology region." 
Today, the src gene is under 
intensive study in the laboratory of 
Rockefeller professor Hidesaburo 
Hanafusa, as well as in the laborato­
ry of Marilyn R�sh, a cancer 
researcher at Sloan-Kettering 
Institute for Cancer Research (see 
"Cracking Cancer's Secret Code," 
page 16). Together, these two scien­
tists provided the guidance and 
insights that enabled researchers in 
the Kuriyan lab to use the tech­
niques of molecular biology to pro­
duce the large quantities of the src 
SH2 domain they needed for their 
studies. 
The Kuriyan lab used the tech­
niques of x-ray crystallography to 
derive their 3-D structure. This 
method bombards crystallized pro­
teins with x-ray beams. The beams 
bounce off electrons whirling 
around individual atoms within the 
crystal, and then scatter ("diffract") 
in all directions. The pattern of this 
diffraction can be interpreted to 
reveal the 3-D structure (see "\Vb.at 
is x-ray crystallography?", page 12). 
The Kuriyan and Cowburn labs 
embarked on their projects indepen­
dently, but they soon learned about 
one another's research. "Rockefeller 
has a very high c.oncentration of labs 
working on biological problems 
without departmental barriers. You 
tend to talk to a lot of people," 
Kuriyan says. 
Scientists in the Cowburn lab 
had synthesized small tyrosine­
phosphorylated protein segments 
(called peptides) as part of a series of 
studies; but, for technical reasons, 
NMR could not visualize these pep­
tides bound to the abl SH2 domain. 
The Cowburn lab provided the pep­
tides to the Kuriyan lab. \Vb.en they 
were 'mixed with the src SH2 
domains, crystals resulted that were 
close to ideal for the x-ray crystallo­
graphic studies. The Cowburn 
group also provided the Kuriyan lab 
with some data on the abl SH2 
domain derived from their NMR 
studies. 
REVEALING THE 
FORCES THAT BIND 
The structures revealed by the 
research groups show that the SH2 
domains have a novel socket-like 
area that binds the region of the 
switch protein containing phospho­
rylated tyrosine. By revealing this 
area of the SH2 domain on an atom­
by-atom basis, the structures give 
powerful insights into the various 
forces that contribute to the bind­
ing. The structures also show that, 
as a whole, the SH2 domain has a 
modular aspect, thus explaining how 
SH2 domains can 
first-ever view of any bound tyro­
sine-phosphorylated peptide.) 
"Comparing these two structures 
allows us to see the SH2 domain in 
both its 'on' and 'off' states," 
Kuriyan points out. The double 
view presents unparalleled insights 
into how this crucial linker protein 
may bind to cellular switches and 
pass the signal along .. Ultimately, 
such insights may lead to a better 
understan4ing of how cancer devel­
ops, and to therapies that might halt 
its progress. With a detailed knowl­
edge of how SH2 domains bind to 
tyrosine-phosphorylated proteins, it 
might be possible to build small 
molecular inhibitors that block these 
interactions. Such "rational drug 
design" is still years away, but is a 
distinct possibility thanks to the 
kind of structural information pro­
vided by NMR and x-ray crystallo­
graphic techniques. 
The structures of the src and abl 
SH2 domain are so similar that the 
Rockefeller researchers believe all 
SH2 domains will prove to resemble 
each other overall. But now a new 
question beckons. Though all SH2 
domains probably bind just about all 
proteins containing phosphorylated 
tyrosine, each domain has its own 
characteristic pattern, binding some 
be a part of so 
many different 
kinds of proteins 
(see illustrations, 
page 6). 
In a hotly contested field, 
tyrosine-phos­
p h o  r y l a t e d  
proteins very 
strongly, and 
others only 
weakly. What 
structural fea-
the Rockefeller researchers 
provided the first vievvs of 
Though the 
work of both 
res,earch groups 
resulted in views of 
the three-dimensional struc-
ture of protein regions called tu res make 
each SH2 do­
main different 
from all the 
SH2 domains. 
the 3-D structures 
of SH2 domains, their investigations 
differed in one important way. The 
NMR studies presented a view of 
the domain in its unbound state, 
while the x-ray crystallography stud­
ies visualized it bound to a tyrosine­
phosphorylated peptide. (Not only 
was this a first for studies of SH2 
domains, but it also provided the 
others? Once researchers such as 
Kuriyan and Cowburn can answer 
these questions, they will be closer 
still to a fundamental understanding 
of how cellular messages are com­
municated, and of how they might 
be intercepted when they threaten 
to go awry. 
5 
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� TWO DIFFERENT 
SH2 DOMAINS HAVE 
REMARKABLY 
SIMILAR STRUCTURES 
Research at Rockefeller using 
nuclear magnetic resonance 
(NMR) spectroscopy and X-ray 
crystallography revealed remark­
ably similar three-dimensional 
structures for the SH2 domains 
of two different proteins. They 
show that the domains of both 
proteins have a novel socket-like 
area that can bind small protein 
regions (peptides) containing 
phosphoryla ted tyrosines-su b­
stances that s'erve as an impor­
tant "switch" to pass along cellu­
lar messages. The NMR studies 
provided a view of an SH2 
domain in its unbound state 
(top), while the x-ray crystallog­
raphy studies visualized a 
domain bound to a tyrosine­
phosphorylated peptide, shown 
in white (bottom). Comparing 
these two structures allows the 
researchers to see SH2 domains 
in both their "on" and "off" 
state-an important advance in 
understanding the details of cel­
lular communication. The struc­
tures also show that, as a whole, 
an SH2 domain has a modular 
aspect. The two ends of the 
domain are close to one another 
and form simple strands that can 
easily insert into any number of 
proteins, while the bulk of the 
protein takes the characteristic 
twists, turns, and loops that are 
essential to its function. This 
modularity explains how SH2 
domains can be a part of many 
different kinds of proteins essen­
tial for cellular communication. 
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DAVID COWBURN 
Since the start of his research 
career, Rockefeller faculty mem­
ber David Cowburn has been 
fascinated by the relationship 
between the structure and func­
tion of biological molecules. 
Cowburn and his colleagues 
were among the first to .realize 
the potential of nuclear magnet­
ic resonance (NMR) spec­
troscopy to reveal a molecule's 
three-dimensional structure. He 
has been utilizing this method 
for over a decade, all the while 
making important contributions 
to its improved sensitivity and 
versatility. 
David Cowburn joined The 
Rockefeller University in 1973. 
He received his Ph.D. from 
King's College at The Univer­
sity of London in 1970. After a 
postdoctoral fellowship at the 
European Molecular Biology 
Organization, he conducted 
interdisciplinary research in 
neurobiology and psychiatry at 
Columbia University's College 
of Physicians and Surgeons 
before coming to Rockefeller. 
In addition to his work on 
the SH2 domain of the abl pro­
tein, Cowburn and his col­
leagues are cooperating with 
researchers at Rockefeller and 
elsewhere to explore the struc­
ture of· other SH2 domains and 
the tyrosine-phosphorylated 
proteins to which they bind. 
Another of his projects is an 
investigation of the 3-D struc­
ture of adenylate kinase, an 
enzyme that catalyzes an essen­
tial step in the conversion of 
food to energy. Still other pro­
jects using NMR seek to discov­
er the structure of growth fac­
tors and hormones, substances 
that set the cellular communica­
tion process in motion by bind­
ing to receptors located at the 
cell surface. 
... 
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<Ill JOHN KURIYAN 
The x-ray crystallographic stud­
ies of Rockefeller faculty mem­
ber John Kuriyan draw on a 
combination of experimental 
and theoretical approaches to 
derive a molecule's 3-D struc­
ture. They aim to understand, at 
the level of atomic detail, how 
proteins function as part of the 
cellular machinery. 
John Kuriyan joined The 
Rockefeller University in 1987, 
after receiving his Ph.D. from 
the Massachusetts Institute of 
Technology in 1986 and com­
pleting a postdoctoral fellowship 
at Harvard University. He was 
named Assistant Investigator of 
the Howard Hughes Medical 
Institute in 1990. 
In addition to the src SH2 
domain and the protein region 
to which it binds, a number of 
other cellular "machines" are 
currently under investigation in 
his laboratory. One such protein 
is a bacterial enzyme that is 
required for the proper folding 
of many proteins. Yet another 
protein under study is DNA 
polymerase III (Pol III), a com­
plex bacterial enzyme involved 
in chromosome replication, one 
of life's most fundamental 
processes. Kuriyan and his col­
leagues have already discovered 
the 3-D structure of Pol Ill's 
"beta-subunit"-one of the ten 
protein components that makes 
up the bacterial enzyme. A long­
term goal of the laboratory 
members is to depict the struc­
tures and explain the functions 
of Pol Ill's nine other compo­
nents. They are also pursuing 
the structures of proteins that 
perform similar functions in the 
cells of plants and animals. 
THE PROCESS OF 
DISCOVERY: RUNNING 
EXPERIMENTS AND 
INTERPRETING RESUL5TS 
Many scientists contributed to 
the discovery of the 3-D struc­
ture of the a bl SH2 domain. 
(Clockwise from right) Postdoc 
N alin Pant, postdoc Carlos Rios, 
and graduate student Michael 
Overduin are members of the 
Cowburn lab. Overduin and 
Rios were key players in running 
the NMR experiments and 
interpreting their results. 
Overduin determined the 
domain's final 3-D structure. 
Pant synthesized short protein 
fragments (peptides) for ongoing 
studies in the Cowburn lab, and 
also provided them . to re­
searchers in the Kuriyan lab for 
use in their studies of the src 
SH2 domain. Rockefeller post­
doc Bruce Mayer (not shown) 
provided the Cowburn team 
with ample quantities of the 
abl SH2 domain for their NMR 
studies. Mayer is a member of 
the laboratory of Rockefeller 
faculty member David Balti­
more, where the cancer-causing 
gene that codes for the abl pro­
tein is under intensive study. � 
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FINDING THE STRUCTURE: 
MANY STEPS, MANY 
SCIENTISTS INVOLVED 
Numerous steps, and numerous 
scientists, were involved in find­
ing the 3-D structure of the src 
SH2 domain bound to tyrosine­
phosphoryla ted peptide. Rocke­
feller scientist Hidesaburo 
Hanafusa, a pioneer in studies of 
the src gene, was among those 
who provided guidance and 
insight to postdoc Dorothea 
Kominos (right) and research 
associate Gabriel Waksman (left) 
in  the Kuriyan lab.  These 
researchers, along with research 
asssitant Scott Robertson (not 
shown), used the techniques of 
molecular biology to genetically 
engineer as much of the src SH2 
domain as they needed to grow 
crystals of the protein. Waksman 
conducted the x-ray crystallo­
graphic studies, interpreted their 
results, and derived the final 3-D 
structure.� 
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What is x-ray 
crystallography? 
X-ray crystallography reveals the three-dimensional
position of every atom in a molecule. The technique
has been used for simple molecules since 1912, but
the first protein structure was not achieved until 1959
after decades of effort. Recently, the pace of discovery
has accelerated remarkably thanks to powerful new
computing and recording equipment that speeds up
the process of data collection and analysis, and to
genetic engineering techniques that vastly increase
the number of proteins available for study.
In principle, x-ray crystallography is similar to, 
natural vision or light microscopy: Electromagnetic 
waves diffract off an object-in this case, the elec­
trons whirling around atoms-and are then refocused 
into an image. But crystallography uses x-rays rather 
than visible light, because only x-rays have wave­
lengths small enough to resolve the interatomic dis­
tances within molecules. Moreover, since x-rays can­
not be focused by any physical lens, crystallographers 
use mathematics to "focus" the diffracted rays back 
into an image. 
A The electrons in a single 
protein molecule would never 
diffract x-rays well enough to 
produce an image, but a crystal 
of protein provides tens of tril­
lions of molecules arrayed in a 
lattice that diffracts x-rays 
strongly. For reasons that 
remain mysterious, growing 
crystals is a chancy business. 
Researchers can coax some 
proteins to crystallize in less· 
than a day, but must labor over 
others for months or years. 
Occasionally, despite their best 
efforts, a satisfactory crystal can 
never be grown. 
Until recently, obtaining 
sufficient supplies of protein 
was also a problem for crystallo­
graphers, since many of the 
proteins they are most eager to 
study are scarce in a cell. Today, 
however, Rockefeller crystallog­
raphers use recombinant DNA 
technology to engineer and 
mass-produce virtually any 
protein they wish to study. 
<II With the crystallized pro­
tein obtained, researchers can 
begin the process of data collec­
tion. An x-ray source shoots a 
beam of waves through the 
crystal. To obtain all the neces­
sary data, experiments are con­
ducted so that the x-ray beam 
hits the crystal at many different 
angles. Most of the waves go 
straight through the crystallized 
protein, but some hit the elec­
trons whirling around the atoms 
and scatter, or diffract, in all 
directions. Interference cancels 
out some of the diffracted 
x-rays, but reinforces others, 
which are recorded on a detect­
ing device. 
At Rockefeller, many 
experiments are conducted 
using a state-of-the-art "area 
detector," which registers many 
diffracted x-ray beams at once 
and sends the information 
directly to a powerful mini-
.,.. The ensemble of diffracted 
beams produces an array of spots· 
called a diffraction pattern. To 
learn more about the individual 
atoms that generated this pattern, 
three aspects of the diffracted 
x-ray waves must be known: their 
amplitude, their wavelength, and
their phase. The intensity of the 
spots on the diffraction pattern 
gives information about the 
waves' amplitude, and the wave­
lengths are known to the scien­
tists from the start. But to solve 
the so-called "phase problem," 
crystallographers must compare 
the diffraction patterns made by
the original crystal with those 
made by crystals of proteins to
which "marker" atoms have been
added. Such comparisons entail 
growing new crystals, running 
scores of additional diffraction 
experiments, and performing 
many complex mathematical cal­
culations. 
Once crystallographers have 
solved the phase problem, they 
can prompt computers to produce 
a preliminary "electron density 
map." The initial map, which 
highlights regions of electron 
density around each atom, is not 
without errors. Nor does it 
unequivocally tag each atom's 
identity, since a number of atoms 
resemble one another at the level 
of detail the map can provide. The 
task of refining and interpreting 
the map is up to the crystallogra­
phers. Drawing on their knowl­
edge of chemistry, physics, and 
mathematics, and referring to the 
known amino-acid sequence of 
the protein, atom by atom they 
build up the structure of the pro­
tein as a whole. .,.. 
When each atom in the electron 
density map has been assigned its 
identity, sophisticated computer 
graphics can present the 3-D 
structure in any number of for­
mats. The protein's secondary 
structure (its helices and strands), 
the peaks and valleys of its sur­
face, the chemical forces that 
shape its internal dynamics, its 
individual atoms-all can be dis­
played in virtually any combina­
tion. These beautiful images, 
which can be moved and rotated 
in all directions with the simple 
click of a computer "mouse," help 
crystallographers decipher the 
innermost details of a protein's 
structure, and thereby provide 
insights into how the protein 
___ :_L . t:. ..• _,: - ·-
Hovv does nuclear magnetic 
resonance spectroscopy vvork? 
Scientists have long used nuclear magnetic resonance (NMR) spectroscopy to 
determine a molecule's chemical composition. But only in the past decade have 
conceptual and technical advances made it possible to use NMR to determine the 
3-D position of every atom in a molecule.
NMR exploits the fact that the nuclei of certain atoms-including hydrogen, 
the most abundant atom in proteins-have an intrinsic spin that makes them act 
like small bar magnets. Differences in the surrounding chemical "environment" of 
each atom affect the behavior of these minuscule magnets in ways that give clues 
to their position within the molecule. This information can then be used to de­
velop a 3-D picture of the protein as a whole. 
� NMR studies protein mole­
cules as they float in solution, 'so 
researchers who use this method 
are freed from the challenges 
x-ray crystallographers must sur­
mount each time they attempt to 
crystallize a protein. But NMR 
poses its own constraints. The 
proteins investigated with this 
method must be highly soluble, 
available in copious quantities, 
and relatively small. 
The NMR spectroscopists at 
Rockefeller conduct the protein 
chemistry necessary to obtain the 
proteins and peptides they study. 
They synthesize certain protein 
segments (peptides) from scratch 
and purify other proteins they 
have "grown" themselves in the 
appropriate culture medium. 
These proteins and peptides are 
dissolved, the solution is poured 
into a glass vial, and the vial is put 
into a ceramic holder before being 
inserted into the NMR magnet. 
� The dissolved protein mole-
cules are subjected to intense 
magnetic fields produced by a 
supermagnet housed in the 
apparatus. The greater the 
strength of the field, the greater 
the sensitivity of the measure­
ments, and the magnet at 
Rockefeller generates fields up 
to 200,000 times stronger than 
that of the earth. The strong 
magnetic field causes the nuclear 
"bar magnets" of certain atoms 
such as hydrogen to line up in 
one of two orientations. 
Generally, the nuclei take the 
orientation that requires the 
least energy. But a boost of extra 
energy in the form of radio fre­
quency waves flips some of the 
nuclear magnets into a higher­
energy orientation. When these 
excited nuclei revert to their for­
mer, lower-energy state they 
emit the absorbed radio energy, 
which can be measured, record­
ed, and analyzed by powerful 
computers. 
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<Ill The characteristic energy 
absorption profile, or spectrum, 
of each atom's nucleus depends 
on many different factors in its 
chemical environment, including 
its own surrounding electrons 
and the nuclei and electrons of 
neighboring atoms. Typically, 
NMR experiments are designed 
to produce spectra that not only 
identify individual atoms, but 
give information about nearby 
atoms, as well. Depending on the 
experiment, these two-dimen­
sional spectra may indicate which 
atoms belong together in the 
same amino acid or which ones, 
though "unrelated," are close 
together in space. Many NMR 
runs are conducted to obtain the 
massive amounts of data required 
to characterize< all the atoms in a 
protein. As one of the first steps 
in analyzing this data, scientists 
draw on their knowledge of 
chemistry, physics, and mathe­
matics, combined with their 
knowledge of the protein's 
amino acid sequence, to develop 
a picture of the protein's "sec­
ondary structure" -the twisted 
helices and crimped, pleated 
sheets that help give a protein its 
shape. 
<Ill With knowledge of the sec-
ondary structure in hand, NMR 
spectroscopists use interactive 
computer programs to help them 
derive a set of "conformers"-a 
number of 3-D structures any 
one of which might be correct. 
Unlike x-ray crystallography, 
NMR does not directly visualize 
the atoms in a protein molecule, 
but rather provides information 
about the atoms' positions rela­
tive to one another. The con­
straints that determine these 
positions lie within strictly 
defined limits. The computer 
program assesses the enormous 
number of permutations that are 
possible within these constraints, 
and generates potential 3-D 
structures. Many of these pro­
posed structures violate the orig­
inal NMR data in some way, and 
the spectroscopists must analyze 
and refine the models. For 
instance, more than 100 struc­
tures were originally generated 
for the abl SH2 domain; in the 
end, the Rockefeller researchers 
identified twenty that best fit the 
NMR data. 
One or more of these structures 
can be chosen for imaging with 
powerful computer graphics pro­
grams. Like x-ray crystallogra­
phers, NMR spectroscopists use 
programs that allow the images 
to be moved and rotated in all 
directions. These programs por­
tray the protein's three-dimen­
sional structure-the characteris­
tic conformation of twists, pock­
ets, and projections that endows 
it with exactly the right combina­
tion of chemical, mechanical, and 
electrostatic forces to perform its 
function. Researchers can select 
any combination of the protein's 
features-its sheets, loops, and 
helices, its individual atoms, its 
surface area, and its electric 
charges-to focus in on particu­
lar functional aspects they wish to 
study. T 
Faculty Profile 
Cracking Cancer's Secret Code 
Hidesaburo Hanafusa and the One Genes 
"All things are hidden, obscure, and debatable if the 
cause ot the phenomena be unknown," Louis 
Pasteur once observed. "But everything is clear if 
this cause be known." 
The words of the great French chemist readily 
apply to cancer. For years, scientists and clinicians 
knew it only as an insidious disease that ravaged the 
body, but its central mechanism, the trigger that 
propelled it along its fatal course, was a mystery-
until about a dozen or so years ago, when cancer 
was determined to be a disease of the genes, and, 
more specifically, a disease spawned by a certain 
group of genes. Known as oncogenes (from the 
Greek, onkos, meaning "mass"), the first cancer­
causing genes researchers discovered were a class 
that started out as harmless as those that code for 
our eye and hair color. The normal function of 
these genes, now referred to as protooncogenes, is 
to promote cell growth and division. Occasionally, 
something-perhaps chemicals, radiation, or some 
other physical carcinogen-damages their genetic 
structure, and transforms them into the potentially 
deadly oncogenes that promote the uncontrolled 
cell growth that is cancer. Another class of cancer­
causing genes-known as anti-oncogenes, or tumor 
suppressor genes-has as its normal task the halting 
of cellular growth; changes in these genes can also 
result in the development of cancer. 
DELVING INTO CELLULAR 
TRANSFORMATION 
But while the discovery of the cancer-causing genes 
makes it possible to understand how cancer origi­
nates, it does not in itself explain what jams a nor­
mal gene's regulatory signals and converts it into a 
hostile oncogene, nor how a turned-on oncogene 
wreaks havoc in the cells. At The Rockefeller 
University, a tumor virologist with a penchant for 
protein chemistry, Hidesaburo Hanafusa, has been 
unraveling the complex mechanism of cellular 
transformation. Delving deeply into the molecular 
basis of cancer, Hanafusa is, in a sense, an engineer 
trying to determine the cause of a communications 
breakdown: he searches for flaws in a cell's "wiring," 
for a malfunction in the equipment that sends, 
John Langone, former medical writer at Discover and Time magazines, is 
working on a book about research and education at the Harvard Medical 
School. 
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relays, and receives the chemical messages a cell 
needs to function smoothly, for errors in the signals 
themselves as they beam from within a cell, and 
between cells. "There are," he says, "a lot of combi­
nations, a lot of possibilities for some mistake. But I 
think the progress we've all made in oncogenesis is 
phenomenal. Gradually, too, we've learned more 
and more about the key elements in all of this, the 
proteins that can disrupt the cell's regulatory mech­
anism." 
Hanafusa's interest in cellular genes and onco­
genesis-the topic of the series of Darwin Lectures 
he delivered at Rockefeller in 1985-began some 
thirty years ago, when he was working on the Rous 
sarcoma virus as a postdoctoral fellow at the 
University of California, Berkeley. It was 1961, a 
time when the very foundations of molecular biolo­
gy were being laid. Newly arrived from his native 
Japan, where he received his B.S. and Ph.D. degrees 
in biochemistry from Osaka University, Hanafusa 
almost immediately took up where Peyton Rous, 
who in 1911 had isolated the chicken tumor virus 
that bears his name, left off. 
STUDYING THE ROUS SARCOMA VIRUS 
Rous had been invited in 1909 to The Rockefeller 
Institute, as it was then called, to continue studies of 
transplantation of tumors. Fortunately, he didn't 
heed the advice of a mentor, who told him earlier 
"not to commit deeply on cancer problems." A few 
years later Rous described an infectious agent which 
would turn out to be a retrovirus. But Rous didn't 
pursue his find because cancer research was too 
primitive, and there was little knowledge of viruses 
in general, let alone the genetic materials that com­
posed them. Indeed, the first electron microscopic 
photographs of Rous's virus were not available until 
1947. They were made at Rockefeller by Albert 
Claude and Keith Porter. 
At Berkeley, Hanafusa's interest in the Rous 
virus peaked ("We had the technology now to pay 
more attention to the implications of Rous's 
groundwork," says Hanafusa), and soon he had 
made several pioneering contributions that Rous 
himself would live to see. One was the finding that 
for the Rous virus to replicate, it required a protein 
provided by a helper virus. This notion of a "defec­
tive" Rous virus-defective in the sense that it was 
unable to produce an essential envelope glycopro­
tein on its own-presaged what scientists refer to as 
transduction-the transfer of genetic material from 
one cell to another-of 
Rockefeller University, in his introduction to 
Hanafusa' s Darwin Lectures. 
While the evidence for virus-induced cancers in 
humans is still lacking, viruses like the one isolated 
by Rous have enabled scientists to analyze the 
mechanism of cell transformation. Says Hanafusa: 
"Studies of these viruses have had a profound 
impact on cancer research 
oncogenes. After thl�y 
found oncogenes in viruses, 
scientists would also uncov­
er, in animal cells, genes 
with exact counterparts to 
the viral oncogenes. Re­
searchers would also find 
segments of DNA related 
to the v-src oncogene in the 
normal DNA of uninfected 
chickens. Today, scientists 
know that viruses can hijack 
bits of cellular DNA and 
Hanafusa is, in a sense, an engineer 
when the viral genes 
responsible for the trans­
forming activity were found 
to have originated from cel­
lular genes, the expression 
of which is critical in car-
trying to determine the cause of a 
communications breakdown: he 
searches for flaws in a cell's "wiring," 
for a malfunction in the equipment cinogenesis." 
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that sends, relays, and receives the 
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function smoothly. 
incorporate them, sometimes damaged, into their 
own genetic material; and, more important, that 
cancer-causing genes are present in normal cells 
before the cells �are infected by retroviruses. "If we 
had pursued the basis of defectiveness," says 
Hanafusa, "we could have reached the current idea 
of transduction of oncogenes much earlier." 
(Hanafusa didn't do so because soon after he discov­
ered the defectiveness of the Rous virus, some non­
defective versions were found in viruses kept in 
Europe. It turned out that they were, as Hanafusa 
puts it, "exceptional viruses.") 
LEADING THE FIELD IN RNA 
TUMOR VIRUS RESEARCH 
Hanafusa left Berkeley, and after stints as a visiting 
scientist at the College de France in Paris and as a 
member of New York City's Public Health 
Research Institute, he joined Rockefeller as a pro­
fessor in 1973. Perhaps it was his Ph.D. thesis 
research on the protein chemistry of enzymes that 
spurred his later interests and accomplishments, 
among them his descriptions of the mechanism of 
genetic information in normal cells that comple­
ment defective viruses, and his isolation of mutants 
that provided evidence for the role of a viral protein 
in transformation. Whatever it was, Hanafusa "has 
been the acknowledged leader in the study of the 
genetics of RNA tumor viruses," observed Purnell 
W. Choppin, head of the Howard Hughes Medical
Institute and former professor and dean at The
For that reason, Hanafusa 
has long been interested in 
the v-src (pronounced 
"sark") oncogene that was originally found in the 
Rous sarcoma virus. The gene, like some other 
oncogenes, encodes a protein tyrosine kinase that is 
solely responsible for initiating and maintaining the 
many different changes that accompany cellular 
transformation. Hanafusa has been investigating the 
role the src gene plays in the cell's signaling appara­
tus, and where it gets involved along the signaling 
track. The signaling process is a complicated one 
involving a chain of intracellular messages and 
interactions known as phosphorylation. 
Hanafusa has found that upon infection with 
Rous sarcoma virus, many cellular proteins become 
phosphorylated on tyrosine, which is associated 
with alterations in a number of cellular structures, 
and functions such as cell growth. 
Hanafusa has also been hunting for a src-phos­
phorylated protein that does its relay work on serine 
or threonine. This one is most important because, 
according to Hanafusa, serine/threonine kinases are 
generally active close to the cell's nucleus, near the 
end of the signaling process. Hanafusa's team has 
discovered such a src-serine/threonine connection 
that may play a key role in cell regulation and which 
might help to explain the runaway division process 
that turns a cell savage and, thus, cancerous. 
Hanafusa has also identified a novel oncogene, 
erk, in an avian sarcoma virus, which was isolated in 
the early 1920s by Albert Claude, another pioneer 
of cell biology at The Rockefeller Institute. It 
encodes a protein that has no known catalytic func-
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Graduate student Heidi Greulich and her 
faculty adviser, Hidesaburo Hanafusa, 
viewina a colonv of transformed cells. 
tion, but surprisingly induces tyrosine phosphoryla­
tion of some cellular proteins, and causes cancer. 
Just how the erk oncogene interacts with other pro­
teins to transform a normal cell into a cancerous 
one is currently under intense investigation, as is the 
role of its mystery protein in normal cells. It is the 
research of this protein that initiated the current 
surge of interest in the _interaction between phos­
photyrosine-containing proteins and a peptide 
sequence known as SH2. 
SETTING THE STAGE FOR 
SOLVING THE CANCER PROBLEM 
Hanafusa's research, like that of all scientists who 
work at the molecular level, is not directly related to 
the treatment of cancer. No more than one turned­
on protooncogene relates to the transformation of a 
healthy cell into a cancerous one. However, both 
the research and the role of the oncogene are 
steps-essential ones-toward something. The 
activation of a protooncogene or the deactivation of 
an anti-oncogene contribute to the development of 
cancer amid a whole range of genetic changes, out­
side influences, and collaboration with other genes 
and oncogenes. The myriad molecular events that 
are examined piecemeal in Hanafusa's and other 
labs set the stage for successful treatment that will 
surely come one day. Without basic research in cell 
and molecular biology, biochemistry, and biotech­
nology, it wouldn't be possible to make other 
advances, such as drugs that block the interactions 
or change the signals that contribute to a normal 
cell's transformation to a cancerous one; drugs that 
work against the protein products of oncogenes; or 
a way to repair the machinery that has gone awry in 
a tumor suppressor gene. 
Hanafusa, like his colleagues in other 
Rockefeller cancer labs, voices hope that these 
advances will soon take place. Reflecting on his 
years in the field, Hanafusa observes, "Since I start­
ed to work in this area, there have been many sur­
prises that will help us solve the cancer problem." 
One indication that Hanfusa is the right man 
for the job is the many awards he has received: the 
Lasker Award for Basic Medical Research, the 
Howard Taylor Ricketts Award, the Asahi Prize, 
and the Clowes Memorial Award of the American 
Association of Cancer Research. Another is the 
description of the man and his contributions by one 
of his fellow tumor virologists: 
"Everything that Hide.saburo does has substan­
tial impact on the field. He has a unique talent for 
sensing the important, and avoiding the trivial." RU 
Rockefeller's Transgenic 
Service Laboratory 
"Oh hi:�ve new world, 
that has such people in't." 
-Wtlliam Shakespeare,
The Tempest 
The Rockefeller University's 
new Transgenic Service Lab­
oratory is a busy hub of activity 
on the fifth floor of the 
Laboratory Animal Research 
Center (LARC). The lab serves 
as the university's core facility 
for the creation and mainte­
nance of all transgenic animals, 
the freezing and preservation of 
mouse embryos, the refinement 
and development of new trans­
genic techniques, and the train­
ing of university personnel. 
Since the laboratory opened 
recently, inquiry calls have been 
coming in from research ins ti tu­
ti on s around the country. 
"We're unique in providing so 
many different services in one 
facility. People want to learn 
more about what we're doing," 
says LARC director Michael 
Hayre. 
The interest is great because 
transgenic techniques are play­
ing an ever-increasing role in 
biological research. These tech­
niques allow researchers to 
change an animal's natural 
genetic endowment by adding or 
subtracting virtually any genes 
they desire. Such manipulations 
permit a wide range of studies, 
from basic research into a gene's 
function to the creation of ani­
mal models for diseases. So far, 
most transgenic studies use 
mice, but other animals such as 
Susan Blum is a science writer in The 
Rockefeller University Public Affairs Office. 
birds and fish also offer promise 
for productive investigations. 
In one transgenic method, 
the gene of interest is inserted 
into fertilized mouse eggs, which 
are then implanted into "surro­
gate" mouse mothers. Some of 
the offspring of these surrogates 
carry the added gene in every 
cell of their body. This method, 
though extremely useful, can 
present certain drawbacks. For 
example, researchers cannot 
control where the gene will be 
inserted into each egg's chromo­
somes, so they cannot be sure it 
will have the same effect in 
transgenic animals descending 
from different eggs. A newer 
transgenic method, called "gene 
targeting," is more complicated 
but allows for greater control. 
By exploiting chromosomes' 
natural propensity to shuffle, or 
recombine, it allows researchers 
to completely debilitate one of 
an animal's normal genes or to 
replace it with another of their 
own devising. 
The skilled staffers at 
Rockefeller's transgenic service 
lab are expert in both types of 
transgenic techniques, providing 
an unusual combination of capa­
bilities that is a boon to re­
searchers. The facility primarily 
serves the Rockefeller communi­
ty, but scientists from other in­
stitutions are also welcome to use 
it; researchers from as close by as 
Memorial Sloan-Kettering Cancer 
Center in Manhattan, and as far 
away as the University of Hong 
Kong, have already done so. 
Transgenic techniques are 
extremely demanding and time-
by Susan Blum 
consuming. Now that the new 
facility is open, researchers will 
be able to enjoy the benefits of 
the methodology without having 
to cope with its complications. 
"In most cases, if investigators 
give us well-prepared DNA, 
we'll be able to give them back 
transgenic mice," says Anne­
marie Walsh, director of the 
Transgenic Service Laboratory. 
For researchers who prefer to 
perform the genetic manipula­
tions in their own labs, the staff 
of the facility stands ready to 
provide any training that may be 
required. 
In addition to creating 
transgenic animals, the facility. is 
one of the few nationwide to 
freeze and preserve transgenic 
mouse embryos. This "cryo­
preservation" cuts research costs 
substantially-and reduces the 
use of laboratory animals-by 
minimizing the number of 
breeding animals that must be 
maintained. The technique also 
ensures that genetically altered 
lines of mice are protected from 
the infections, accidents, and 
"genetic drift" that can threaten 
precious transgenic strains. 
When transgenic mice are 
required for research, the 
embryos need only be thawed 
and implanted in surrogate 
mothers. Studies recently com­
pleted in the lab show that cryo­
preservation does not harm the 
embryos in any way. 
Lab members are also 
researching better methods to 
freeze mouse sperm-an accom­
plishment that, like cryopreser­
vation, would help save money 
Above, Research Assistant Kirk Economides 
microinjects mouse eggs with foreign DNA 
to produce a new strain of transgenic mice 
that will help researchers understand the 
and reduce the number of lab 
animals used. It has long been 
possible to freeze the sperm of 
many other mammals from rats 
to humans, but for reasons that 
remain unknown the sperm of 
mice is much harder to freeze. 
The researchers at Rockefeller 
are using new techniques devel­
oped in England to surmount 
the difficulties of this tricky pro­
cedure. 
That project is just one of 
many now under way or planned 
for the future at the new 
Transgenic Service Laboratory. 
Currently, for instance, Walsh 
and Carol Novotney, a veteri-
22 
nary postdoctoral fellow at 
LARC, are exploring methods 
to create transgenic quail. Most 
other groups involved in such 
efforts are interested in benefit­
ing the poultry industry. But the 
researchers at Rockefeller 
believe transgenic birds would 
be a boon to the biomedical 
research community, too. 
As the studies of Rocke­
feller scientists such as Fer­
nando Notte bohm and Arturo 
Alvarez-Buylla have shown, 
birds serve as excellent models 
for neuro biological studies and 
for research in basic biology. 
The ability to manipulate birds' 
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genetic endowment would fur­
ther enhance the insights such 
studies might provide. Though 
the characteristic internal struc­
ture of avian sperm and eggs has 
so far thwarted the development 
of transgenic birds, the team at 
the Transgenic Service Labora­
tory believes the obstacles can 
ultimately be overcome. 
Development of the Trans­
genic Service Laboratory 
was facilitated by a gift of 
$150,000 from the Schering­
Plough Research Institute, the 
research division of the major 
pharmaceutical company in 
New Jersey. Michael Hayre has 
long-standing ties with Schering­
Plough, having served as the 
company's associate director of 
animal care before becoming 
LARC's director in 1991. "We 
are enormously pleased that 
Schering-Plough has made such 
a generous contribution to our 
new facility," Hayre said. "My 
ties of affection and admiration 
for both Rockefeller and 
Schering-Plough are enormous, 
and I'm delighted that we have 
been able to build this bridge be­
tween the two institutions." RU 
Top, Susan Powell, director of cryogenic preserva­
tion services, retrieves a vial of frozen mouse 
embryos. Bottom, Research Assistant Michelle 
Inserra, left, and Annemarie Walsh, Pi{lht, director 
of the Transgenic Service Laboratory, review data 
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Dedication Ceremony 
Keynote Address 
by Walter E. Massey 
Director, The National Science Foundation 
I have often thought that if I had to live life over 
again I would become a historian. I have made a 
hobby of learning history because I believe passion­
ately that we must know history in order to under­
stand and appreciate current events, and to inform 
our decisions about the future. In this new research 
building, I see lots of history; and it also inspires me 
to think about the future. 
Both mystery and certainty are at work here. 
We cannot predict what new knowledge will be 
unveiled within the walls of this building. But we 
also are certain that great advances will come forth 
from within these walls sooner or later. Some man 
or woman, perhaps someone here today, might 
someday discover a cure for AIDS, or an affordable 
pollution-free energy source, or any number of less 
dramatic discoveries that bring added convenience 
and enjoyment to daily life. This mystery-that we 
cannot predict precisely what we will learn-com­
bined with the certainty that great things will occur, 
is the essence of scientific and technological 
progress. It underlies all of the contributions that 
science and technology have given to society 
throughout history-from the first wheel to the 
most advanced supercomputer. 
I also believe that the historical importance of 
this dedication extends far beyond this building and 
the research it will house. This building is a vivid 
reminder that science in America owes much of 
its development to the farsighted individuals 
who devoted their fortunes to the progress of 
knowledge. 
It staggers the mind to try to imagine what it 
would take today to match the accomplishments of 
the Rockefellers, Carnegies, Stanfords, and a gener­
ation later, Hughes. Such individual largesse erected 
universities, research institutes, and facilities that 
enabled the nation to begin its ascendency in funda­
mental science and engineering. 
The dollar amounts behind these efforts of a 
century ago-generally in the millions or tens of 
millions-may not sound great by today's standards. 
But it is worth remembering that when this great 
institution was founded· in 1901, the entire Federal 
budget totaled only a few hundred million (and, by 
the way, it even ran a surplus in some years), a sue-
')/1 
cessful wage-earner might draw ten dollars a week, 
and you could probably still find a good five-cent 
cigar. 
I give you these figures only to provide some 
indication of how difficult it would be to duplicate 
this generosity today. Yet without the wisdom and 
foresight of these individuals, I am convinced that 
America would not have been able to become the 
wellspring of progress and knowledge that it is 
today. 
\Vhen this institution was founded, the Federal 
government's interest in science and engineering 
did not extend very far beyond surveying and map­
making. Virtually all of fundamental research and 
graduate education was supported by private and 
philanthropic sources. Years later, when the govern­
ment had matured enough to recognize the need for 
a continuous supply of new knowledge and scientific 
talent, the research infrastructure fortunately was 
already in place. Since then, this research and edu­
cation enterprise has laid the foundation for an 
unbelievable string of discoveries, inventions, Nobel 
Prizes, and economic progress. 
Whenever an institution engages in a project of 
this size and scope, it is natural and appropriate to 
ask questions about the institution's future role, 
mission, and responsibilities. I would like to offer a 
couple of thoughts about the future of The 
Rockefeller University. 
First, never lose sight of the unique capabilities 
of this institution. The value to the nation of a pure 
research institution cannot be matched anywhere 
else. By providing an unfettered atmosphere, the 
nation's best minds are free to follow their imagina­
tion and curiosity. It is truly amazing to have all of 
this in the middle of the city that never sleeps. 
Second, and closely related, is the fact that the 
frontiers of science today often fall along the 
boundaries of existing disciplines. The Rockefeller 
University realized this early in  its history. 
Although it was founded as a medical institute and is 
still largely focused on human health, it recognized 
the need to have scientists from other disciplines­
physicists, chemists, engineers-on campus. This 
has helped give rise to such promising areas of sci­
ence as biophysics and biochemistry. The future of 
science requires that this process of integration con­
tinue, and I fully expect this university to remain at 
the forefront. 
I believe that this process of integration will be 
a guiding force in the future for all of science. And 
once again, my thoughts are inspired by what I have 
learned about this building. Since I arrived on cam­
pus to join in these festivities, more than one person 
has said to me that this may well be last time we see 
a research building of this capacity built entirely 
with private funds. 
The construction of this building combined the 
forces of two names which are synonymous with the 
can-do attitude that made America great: 
Rockefeller and Hughes. The nation is very fortu­
nate for that. But we have reached an age where 
even with such stature behind the project, the end 
result is just a shell in many respects. To put it sim­
ply, somebody else has to buy the furniture for half 
of the floors in this building. 
I expect that the somebody who buys the furni­
ture and instruments will be a combination of all of 
us-government agencies like the National Science 
Foundation and the National Institutes of Health, 
the city and state governments may choose to par­
ticipate, and without a doubt so will private corpo­
rations and industrial groups that need advanced 
knowledge for comparative advantage. The opening 
of borders around the globe could also bring forth 
new partnerships. 
The challenge of furnishing this building is 
symbolic of the future of the entire research enter­
prise. I believe that the future of research will 
involve increased cooperation, partnerships between 
institutions, sharing knowledge, exchanging ideas, 
and combining resources more than ever before. 
There are changes occurring that make it clear 
we cannot continue supporting research as we have 
in the past. We are witnessing a growth in cost and 
scale unlike anything in history: laboratories, like 
the ones we see here for example, require the most 
modern controls on wastes and emissions to comply 
with government regulations. We have also moved 
decades beyond the days when equipping a labora­
tory was a simple as putting a microscope on a lab 
bench. 
And, when it comes to the administration of 
research, sometimes it seems we are just running in 
place. At NSF, we reject almost twice as many pro­
posals as we fund. And those we fund receive only a 
bare minimum in terms of support; the average 
grant generally enables a senior scientist to hire just 
one graduate student. Some people say more human 
Above right, Walter Massey, Purnell Choppin, 
and T orsten Wiesel at the dedication ceremony 
for the John D. Rockefeller, Jr. and David 
Rnrlrofollor l=loc-o::lrrh R11ilrlinn l::i�t �P.ntP.mhP.r 
energy is expended reviewing research proposals 
than conducting the research itself. 
Despite these disconcerting facts, however, the 
knowledge generated by investments in research 
and education is more vital and valuable to the 
nation than ever. There is great excitement about 
the potential that many recent discoveries hold for 
the nation's future: areas like superconductivity, 
which could reduce energy consumption and lead to 
new forms of transportation; or biotechnology, 
which holds the promise of new drugs and tech­
nologies to clean the environ�ment. 
All of this adds up to a complicated picture of 
the research enterprise as it approaches the twenty­
first century-dynamic and vital, but also disgrun­
tled and pessimistic. 
The picture of the future of research would not 
be complete without saying something about the 
end of the cold war. No one of us can deny that 
superpower tensions shaped many of our national 
research and development priorities-from the 
space race to Star Wars. Many disciplines, especially 
in physics and engineering, grew up as offshoots of 
weapons programs. Many areas of research in the 
life sciences as well, including the human genome 
project, have roots in national security objectives. 
Even today, three years after the fall of the Berlin 
Wall, almost sixty cents of every dollar the govern-
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ment spends on R&D is earmarked for defense, the 
same level as a decade ago. 
With the rapid decline of the Soviet Union at a 
time of steady growth in economic power in Europe 
and Asia, there are new expectations for research in 
this country. Many of the underlying rationales for 
public support of science are changing. At the 
height of the cold war, people viewed science as 
insurance against technological surprise from an 
adversary. Today, the nation increasingly looks to 
science as the source of the technological advance 
necessary for economic prosperity and an improved 
quality of life. 
The research enterprise should not try to insu­
late itself from these forces of change. To do so 
would not only be a mistake, it would be impossible. 
The future vitality of research depends on our abili­
ty to be as creative and forward looking in the 
future as people like John D. Rockefeller were a 
century ago. 
At the National Science Foundation, we have 
begun a very thorough process of identifying the 
most effective ways to continue serving the nation 
and promoting the progress of science and engi­
neering. I am certain that whatever NSF does in the 
future must be premised on continued strong sup­
port for the fundamental research that is so valuable 
to the country. We must build on this strength and 
help the nation capitalize on its preeminence in 
fundamental science and engineering. 
We must develop strategies that continue to 
give academic researchers the independence they 
need in order to achieve success. But we must do 
more to move quality research quickly to those who 
can use it for innovative applications. Cooperation, 
integration, and exchange of ideas-this is the hall­
mark of research in the future ... and also what I 
believe will put furniture in this building. 
John F. Kennedy once said that "History . . .  has 
no present, only the past rushing into the future. To 
try to hold fast is to be swept aside." 
The dedication of this building gives us the 
chance to celebrate a slice of the history of science 
in America. It also serves as a reminder of the chal­
lenges and opportunities that the future will bring . 
.... 
Above left, The Rockefeller Research Building 
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The Rockefeller University and 
The Hovvard Hughes Medical Institute 
Collaborating to Further 
Scientific Discovery 
The opening of the John D. 
Rockefeller, Jr. and David 
Rockefeller Research Building 
marks a major collaboration in 
modern science. The structure 
symbolizes the joined forces­
and shared philosophy-of two 
prominent institutions dedicated 
to biomedical research-The 
Rockefeller University and the 
Howard Hughes Medical 
Institute (HHMI), the largest 
private philanthropy in the 
nation, which contributed over 
$3 3 million to the cost of the 
new building. Says Torsten 
Wiesel, Rockefeller's president, 
the institutions' common out­
look "strikes to the heart of the 
whole scientific enterprise: Find 
the most talented researchers 
possible, and then give them the 
facilities and the freedom to pur­
sue their studies wherever they 
might lead." 
The collaboration is particu­
larly meaningful for both institu­
tions because HHMI's president, 
Purnell W. Choppin, spent much 
of his career as a research scien­
tist, dean, and scientific administra­
tor at The Rockefeller University. 
"Among those to whom this 
occasion means something very 
special I certainly count myself," 
said Choppin at the building's 
dedication ceremonies last 
September. "I cannot avoid 
some very personal feelings 
Right, Purnell Choppin, head of the Howard 
Hughes Medical Institute (HHMI). and his 
wife, Joan, flank Nathaniel Heintz in his labora­
tory in the new Rockefeller�research building. 
Heintz, an HHMI investigator, was the first uni­
versity faculty member to move his lab into the 
nnw fof'ilit11 f11nrlorl in n'.:lrt thrn11nh 1-ll-H,AI 
because I have been privileged 
to have long personal associa­
tions with both the very special 
place that The Rockefeller Uni­
versity is, and another unique 
and great institution, the 
Hughes Institute." 
Before joining HHMI as 
vice president and chief scientific 
officer in 1985, Purnell Choppin 
spent twenty-eight years at The 
Rockefeller University studying 
the mechanisms by which 
influenza and measles viruses 
produce cell injury and disease. 
When he left the university he 
was a senior physician and the 
Leon H�ss Professor of Virol­
ogy, and served as vice president 
for academic programs and dean 
of graduate studies. 
"Clearly my years there 
imbued me with respect for 
thoroughness and excellence," 
Choppin explains, "and the 
importance of unfettered time to 
perform research. If one comes 
from an institute of that order, 
he looks on research with the 
highest possible standards." 
HHMI SUPPORTS 
RESEARCH AND 
LAB SPACE 
The relationship between The 
Rockefeller University and The 
Howard Hughes Medical 
Institute exemplifies HHMI's 
method of support. Once 
HHMI enters a collaborative 
agreement with a host institu­
tion, it not only brings faculty 
scientists onto its research stiff,
but arranges for their laboratory 
space either by leasing existing 
facilities or by participating 
financially in the construction of 
a new building and then occupy­
ing some of the new facilities. 
An arrangement for new con­
struction was reached between 
Hughes and The Rockefeller 
University at the time of their 
contractual agreement in 1985. 
At that time, HHMI pledged 
funds toward four floors of the 
new research facility that opened 
its doors this fall. 
"There is no other ins ti tu­
ti on in the United States that 
operates quite like Hughes," says 
Choppin. "As an operating med­
ical research organization, 
HHMI enters into partnership 
with outstanding universities and 
medical centers, collaborations 
to which each brings important 
resources-human, environmen­
tal, and financial. It is an unusual 
arrangement in which HHMI 
investigators become Institute 
employees but remain as faculty 
members of the host institutions, 
carrying out normal teaching 
and other faculty responsibili­
ties. It is complex, but it works­
and we at HHMI are apprecia­
tive of the manner in which our 
partners, such as The Rocke­
feller University, work with us." 
ELEVEN RU SCIENTISTS 
ARE HUGHES 
INVESTIGATORS 
At Rockefeller University, the 
Howard Hughes Medical Institute 
supports eleven scientists whose 
research will soon be carried out 
on four floors of the n�� John 
D. Rockefeller, Jr. and David
Rockefeller Research Building.
HHMI selects investigators 
according to the quality of their 
research. Scientists do not apply 
for HHMI support; they are 
chosen. They are offered renew­
able appointments for varying 
periods of time, depending on 
the rank of the scientist at the 
host institution. Assistant profes­
sors are appointed for terms of 
three years, associates for five 
years, and full professors for 
seven years. HHMI investigators 
heading labs at Rockefeller 
University are Gunter Blobel, 
Stephen K. Burley,· Claude 
Desplan, Michael W. Young, 
Thomas Sakmar, Michel C .  
Nussenzweig, Jeffrey M. 
Friedman, Nathaniel Heintz, 
John Kuriyan, Jan Geliebter, and 
Right, Peggy and David Rockefeller enter 
the new Rockefeller research tower after the 
ribbon-cutting ceremony at the building's 
Yongwon Choi. An additional 
eighty-one people-postdoctoral 
associates, technicians, and other 
support staff-who work on the 
Rockefeller campus are on the\ 
Hughes payroll. In fiscal year 
1992, HHMI's operating budget 
for its Rockefeller University 
projects was $7 .8 million, 
according to Choppin. 
"Hugh es is very generous," 
says geneticist Michael Young. 
"The institute takes you in and 
gives you ample support that is 
realistic to the cost of science. 
There is money for supplies and 
salaries for junior members of 
the lab. Postdocs can work on 
two-, three-, or four-year inde­
pendent projects that relate to 
the larger project, and Hughes 
pays for their work and supplies. 
Money from public and private 
agencies is tight now and a grant 
is often barely enough to cover a 
portion of your work. Hughes is 
more realistic and has more 
awareness of the costs of 
research." 
A VISION FOR THE FUTURE 
The joint efforts of HHMI and 
The Rockefeller University are 
expected to result in significant 
contributions to scientific 
research. Walter E. Massey, 
director of the National Science 
Foundation, said in his keynote 
address at the dedication cere­
mony for the new building 
(reprinted in its entirety on 
pages 24-26): "Both mystery and 
certainty are at work here. We 
cannot predict what new knowl­
edge will be unveiled within the 
�alls of this building. But we 
also are certain that great 
advances will come forth from 
within these walls sooner or 
later. Some man or woman, per­
haps someone here today, might 
someday discover a cure for 
AIDS, or an affordable pollu­
tion-free energy source, or any 
number of less dramatic discov­
eries that bring added conve­
nience and enjoyment to daily 
life." That is the hope-and the 
anticipation-of this philan­
thropic mission that David 
Rockefeller says is "aimed at 
supporting top-quality re-search 
that only the very best in science 
are qualified to conduct." 

F rotn Microbes to Molecules: 
A CENTURY OF SCIENCE AT THE,ROCKEFEiLER UNIVE 
Above, Schermerhorn Farm: Site of the future Rockefeller 
University campus. Inset, Frederick T. Gates and Simon Flexner. 
The Rockefeller Institute for 
Medical Research was incorpo­
rated in 1901, and immediately 
gained local attention by finding 
(as the headlines of the New York
Herald put it) "Germs Swarming 
in City's Purest Milk." The next 
year, Simon Flexner, a young, 
eminent pathologist at the 
University of Pennsylvania, was 
appointed the nascent institute's 
first director. It was Flexner's 
personal venture into the uni­
verse of deadly microbes during 
a 1 904-1905 epidemic of cere­
brospinal meningitis that estab­
lished both The Rockefeller 
Institute's lasting fame and the 
enduring confidence of its bene­
factor, John D. Rockefeller. 
Text by Geoffrey Montgomery 
Photos are courtesy of The 
Rockefeller University Archives 
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American, New York City, June 1, 1908. 
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Under the leadership of this 
master microbe hunter, the mis­
sion of The Rockefeller Institute 
both widened and deepened. fn 
1910, as construction was com­
pleted on a new hospital, 
Flexner recruited the experi­
mental biologist Jacques Loeb, 
an apostle for a physico-chemi­
cal explanation of life's great 
c o n u n d r u m s - h e r e d i t y ,  
embryogenesis, and mind. One 
of Flexner's first appointments 
to Rockefeller, Phoebus Levene, 
revealed the chemical formulas 
of the ill-understood nucleic 
acids .  And in 193 5, Wendell 
Stanley, applying methods 
developed by his Rockefeller 
colleagues working on protein 
chemistry, succeeded in crystal­
lizing the virus responsible for 
tobacco mosaic disease. 
Stanley's crystalline micro be 
caused a sensation. This virus 
that could be turned to crystal 
while retaining its self-replicat­
ing powers seemed to exist on 
the twilight border between the 
living and the dead, between 
reproducing organisms and life­
less molecules. Its protein cap­
sule seemed to hold the promise 
of a true chemical understanding 
of life . Stanley, like Loeb, 
Levene, and nearly all bio­
chemists of the age, thought that 
the elements of reproduction­
genes-must be made of pro­
tein. Yet a strange fact soon 
emerged. Coiled within the cap­
sule of Stanley's magic crystal 
was the molecule Levene had 
first analyzed-a nucleic acid. 
The cornerstone of Founder's for a building that would be opened on May 11, 1906. 
Hall, which housed The commodious but without Within its six floors of brick 
Rockefeller Institute for frills: its style should "be as and stone resided three 
Medical Research's first per- simple as is consistent with departments that represented 
manent laboratories, was its present purpose, future the core disciplines of the 
laid on December 3, 1904. additions, and general utility." early institute: chemistry, 
The lnstitute's Board asked Founder's Hall was pathology, and bacteriology. 
President Oetlev W. Bronk, degrees by the University of ta ins the office of the president 
with Board Chairman David the State of New York. and other administrators, a 
Rockefeller, led the Caspary Hall/Abby small library, the Faculty and 
institute's evolution into Aldrich Rockefeller Hall-a Student's Club, a dining room, 
a university. In 1954 single integrated building and guest accommodations. 
Rockefeller was given the despite its dual name-was Connected to Caspary is the 
power to grant graduate completed in 1958. It con- university's domed auditorium. 
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While Avery the microbe hunter 
discovered that DNA is the stuff 
genes are made of, another mi­
crobe hunter, Albert Claude, led 
science's entry into the fine 
structures residing in the cell's 
gelatinous interior. Trying to 
isolate the famous cancer-causing 
virus that Peyton Rous had dis-
covered in 1 913, Claude pio­
neered in the 1940s the dual 
deployment of electron micros­
copy and biochemistry in unveil­
ing the invisible world of the 
cell. In the mid-1950s, extending 
the work of Claude and Keith 
Porter, George Palade and 
Philip Siekevitz uncovered key 
aspects by which DNA's code is 
translated into proteins-the 
cogs, gears, and girders by which 
cells function. 
For founding modern cell biolo­
gy, Claude, Palade, and Christian 
de Duve shared the 197 4 
Nobel Prize for Physiology or 
Medicine. 
First electron micrograph of a cell. 
Ribosomes-factories for making proteins. 
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Bruce Merrifield and his protein synthesizer. 
SH2 domain coded by Rous sarcoma virus oncogene 
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.f In 1972 Stanford Moore and
� William H. Stein received the
� Nobel Prize for their chemical 
analysis of the protein ribonu­
clease; and in 1984 Bruce 
Merrifield won the Prize for 
artificially synthesizing this same 
protein . Between 1940 and 
1980, Rockefeller scientists voy­
aged from the center of the cell 
and its DNA to the vital protein 
structures DNA encodes. 
In addition, the discoveries of 
Rockefeller's earliest microbe 
hunters continue to bear fruit. 
Just this summer, in a seminal 
collaboration, the labs of four 
Rockefeller professors-David 
Baltimore, David Cowburn, 
Hidesaburo Hanafusa, and John 
Kuriyan-along with Marilyn 
Resh of the Memorial Sloan­
Kettering Cancer Center 
revealed the crystal structure of 
a key cancer-causing protein 
segment, isolated from the 
tumor virus Rockefeller scientist 
Peyton Rous first cultured 
eighty years ago. Through such 
work from its current re­
searchers, Rockefeller's glorious 
past remains very much alive. 
In 1971, the Mary Flagler 
Cary Charitable Trust 
donated a tract of land in 
Millbrook, New York, that 
now serves as the univer" 
sity's Field Research Center 
for Ecology and Ethology. 
The John D. Rockefeller, Jr. 
and David Rockefeller 
Research Building was 
opened in 1992. 
1991-92 Annual Report 
F rotn the President 
Just over a year ago I accepted the responsibility of 
becoming_ president of The Rockefeller University. Most 
of my nearly forty years as a scientist had been devoted to 
research; my previous administrative experience consisted 
of serving as chairman of the Harvard Medical School's 
neurobiology department, as well as a few other small 
assignments. Yet my transition from 
by Torsten Wiesel 
$28.5 million in fiscal 1991-92, and this growth has con­
tinued in the months thereafter. 
The first decades of _this university's existence happi­
ly coincided with the development of an entirely new 
field, molecular biology, which brought together the skills 
and insights� of medical scientists, biologists, chemists, and 
physicists. Through gene therapy and 
the laboratory to the president's office 
went smoothly, thanks in no small 
part to the relationships I had formed 
in my decade on the Rockefeller facul­
ty. The faces on the campus were 
familiar; many belonged to close col­
leagues and friends. These personal, 
trusting relationships, especially with 
members of the faculty and the 
trustees, provided a solid foundation 
for leading this university. 
The university's finances 
have been greatly 
molecular medicine, molecular biology 
now offers a remarkable and unprece­
dented range of diagnostic technolo­
gies and treatment possibilities for 
many of our most-feared diseases: can­
cer, AIDS, heart diseasf, and antibiotic­
resistant tuberculosis, to name only a 
few. This new era of molecular medi­
cine was born at The Rockefeller 
strengthened, and we 
have been able to recruit 
an outstanding senior 
professor and five superb 
University Hospital, and we continue 
to allocate resources to revitalize the 
hospital and keep it at the forefront of 
junior professors. 
I have been fortunate: this has 
been an-auspicious period for Rockefeller. The universi­
ty's finances have been greatly strengthened, and we have 
been able to recruit an outstanding senior professor and 
five superb junior professors. The Rockefeller University 
Hospital has received new leadership and new resources; 
we have added a sixth faculty search committee, in 
physics; and we have witnessed the opening of our mag­
nificent new tower, the John D. Rockefeller, Jr. and 
David Rockefeller Research Building, with 50,000 square 
feet of laboratory space ready for immediate use, and 
�nother 50,000 to be developed on the top six floors. 
These successes, of course, did not arrive miracu­
lously in this first short year of my presidency; they were 
planned, prepared, and begun under the leadership of my 
predecessors, Joshua Lederberg and David Baltimore, and 
were nourished by the crucial support of the Howard 
Hughes Medical Institute. Under Dr. Baltimore's admin­
istration, Fred Bohen, our executive vice president, 
helped to chart a sound course for The Rockefeller 
University's financial future by setting in place a coordi­
nated program of management and financial reforms. 
This tougher-minded allocation of the university's 
resources has continued during my presidency, and it has 
already resulted in a striking decrease in our operating 
deficit-the shortfall between income and expenses that 
has eroded the university's financial strength over the last 
five years. At the same time, the gifts and pledges given to 
the university from private sources have increased dra­
matically, rising from $11.3 million in fiscal 1990-91 to 
40 
this ever-expanding scientific frontier. In February 1992, 
Zanvil Cohn was appointed Vice President for Medical 
Affairs; at the same time, Jules Hirsch became the hospi­
tal's Physician-in-Chief, and Rudy Leibel, a longtime col­
laborator with Dr. Hirsch in studying the biological basis 
of obesity, was named Head of Laboratory. A challenge 
grant from the Herzog Foundation provided crucial sup­
port for our Clinical Scholars Program, which furthers 
the careers of outstanding physician-scientists. These 
developments, as well as the efforts o{our search commit­
tee for medical scientists, will help to maintain the hospi­
tal's central place in this essential field. 
The university continues to expand its basic core 
areas of biomedical research. Three members of our fac­
ulty have been promoted to Head of Laboratory: the 
structural biologist David Cowburn, the medical 
researcher Shigeru Sassa, and · the cell biologist Sanford 
Simon. Three scientists from outside the university have 
been appointed to our junior faculty: Kenji Adzuma, a 
molecular geneticist; Y ongwon Choi, an immunologist; 
and Seth Darst, a structural biologist. Our search com­
mittees in biochemistry, chemistry, and structural biolo­
gy, in cell and developmental biology, and in immunology 
and microbiology continue to seek out outstanding junior 
and senior faculty to join us at The Rockefeller 
University. I have always felt that it is important for the 
university to maintain and develop our small but active 
chemistry and physics programs, and two visiting com­
mittees have conc�rred with me. The university's core 
;Ao. 
mission remains biomedical research, but as I mentioned 
above, the participation of physicists and chemists has 
been crucial to the revolution in cell and molecular biolo­
gy, and the presence of physical scientists will remain an 
essential part of our scientific community. 
Most biomedical scientists will agree with me when I 
say that the next great biological frontier is an increased 
understanding of the workings of the brain, the most 
complex organic structure in the known universe. The 
Rockefeller University is already among the world's fore­
most research facilities in neuroscience, with top-notch 
laboratories investigating the basic mechanisms underly­
ing perception, memory, learning, development, and such 
disorders of the brain 
as depressive illness, 
schizophrenia, and 
Alzheimer's disease. 
We have a search com­
mittee in neurobiology 
seeking neuroscientists 
whose work will com­
plement that of our 
laboratories. The com­
mittee's activity has 
already led to the 
appointment of two 
new junior faculty 
members: Robert Dar­
nell, whose research on 
the brain sheds light on 
problems in immunol­
ogy and cancer, and 
Joseph Atick, a young 
physicist who is devel­
oping mathematical 
models of sensory per­
ception. A major initia­
tive of my administra-
tion has been the development of a Neuroscience Center, 
to be housed in our new research building, which will 
integrate and strengthen the university's efforts in neuro­
biology. The newest member of our senior faculty­
Mary Beth Hatten, a leading developmental neurobiolo­
gist-will play a key role as part of this interactive 
research center. 
The creative life of our scientific community requires 
a strong administrative and support team, and here, too, 
the past year has brought us great successes. We were 
able to attract a superb and experienced administrator, 
Ingrid Reed (who was formerly at Princeton's Woodrow 
Wilson School), to assume the critical roles of Vice 
President for Public Affairs and Corporate Secretary. 
Ingrid serves as liaison among the Board of Trustees, the 
faculty, and the Office of the President; in addition, she 
Above, President Torsten Wiesel talks with stu-
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organizes publications, lectu.res, and special events for 
general audiences as part of an ever-growing effort to 
reach out to the larger community of which our university 
is a part. (Our high school outreach program for science 
education, which was formally instituted last May, is 
another critical component of this effort.) Frank Lees, our 
new Chief Information Officer, comes to us from the 
State University of New York in Albany. He has already 
emerged as an important member of the university's staff 
through his help in integrating the campus's computer 
and communication-services networks. 
In my first year as president, I have discovered how 
fortunate we are to have a Board of Trustees that is gen­
uinely committed to 
the scientific and 
operational principles 
on which the universi­
ty was founded. David 
Rockefeller has served 
on the board for over 
fifty years, and the 
steadfastness of his 
leaders�ip and support 
should serve as a 
model for all other 
research universities. 
Richard Furlaud, 
Chairman of the 
Board of Trustees, has 
been a friend, a part­
ner, and a constant 
source of guidance. I 
would like to welcome 
those trustees who 
have recently joined 
our board: Edward S. 
Cooper, D. Ronald 
Daniel, Evelyn G. Lip­
per, Ernest Mario, Frederick A Terry, and Alair Townsend. 
One of my great pleasures in this past year has been 
the opportunity to meet and work with people from every 
part of the university: trustees, faculty, students, adminis­
trators, and support staff. I believe we are all working 
together in harmony and with a sense of common pur­
pose. As we look toward the future in an ever-changing 
and increasingly competitive world, we must continue to 
set our goals high and be guided by the compass of the 
past. Discoveries at The Rockefeller University have 
played a crucial role in changing the course of scientific 
history: they have added to our understanding of nature 
and of human disease, and have laid the foundations for 
contemporary molecular medicine. Our task is to build on 
these achievements and, through our efforts, enhance this 
noble legacy for those who succeed us. 
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1991-92 Annual Report 
From. the Executive Vice President 
The Rockefeller University accomplished several major 
operational objectives during the course of 1991-92, even as 
presidential leadership passed, without advance planning but 
nonetheless smoothly and cordially, from Dr. David 
Baltimore to Dr. Torsten Wiesel. The university measurably 
strengthened its financial foundations by significantly cutting 
its operating costs and achieving dramatic advances in private 
fund-raising for research. 
Among the operational highlights of the year, the university: 
• Completed construction in June 1992 of a state-of-the­
art, twelve-story research facility-the John D. Rockefeller,
Jr. and David Rockefeller Research Building. This extraordi­
nary $88 million facility adds 100,000 square feet to the uni­
versity's productive research space, increasing it by more
than 30 percent. The building was completed in less than 24
months, slightly ahead of schedule, and more than $4.5 mil­
lion under the total budget authorized by the university's
trustees.
• Consummated the first combined taxable/tax exempt
long-term debt financing undertaken by an institution of
higher education in New York State. With the assistance ,of
the New York Dormitory Authority, the university borrowed
$50 million in July 1991, to cover its share of the construc­
tion costs of the new Rockefeller Research Building, at a
blended taxable/tax exempt interest rate of 7 .1 percent. Even
after this $50 million debt issue, the university's very favor­
able endowment-debt ratio continues to place it comfortably
among the half-dozen research universities in the nation with
the strongest balance sheets, and sustains its Triple-A credit
rating.
• Purchased and installed a new AT&T-manufactured
telephone system which replaced a creaky rented system that
had lasted for more than a decade. The university simultane­
ously recabled the campus with high-capacity fiber-optic
wire that provides a backbone network for state-of-the-art
information and computing services. These improvements
were accomplished through financial arrangements that held
future annual amortization of the capital investment involved
below the annual cost of the equipment and services that
were replaced.
• Invested more than $1. 1 million, including a major
grant from NIH, to upgrade the heating, ventilation, and air
conditioning systems and made other physical plant
improvements in the Laboratory Animal Research Center
(LARC). These improvements will ensure that the university
maintains an outstanding animal care and use program.
In April 1992, Dr. Michael Hayre, the Director of 
LARC, and his staff, received a three-day reaccreditation 
review and assessment by The American Association for 
Accreditation of Laboratory Animal Care (AAALAC). The 
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by Frederick M. Bohen 
university's strengthened program and improved animal­
based research facility won high marks and received contin­
ued full accreditation. 
• Modernized research laboratories in the Tower
Building; expanded the protein sequencing service facility in
the Smith Hall research building.
• Successfully renegotiated with the federal government
the university's rate for reimbursement of necessary over­
head and research support costs, following extensive inde­
pendent audits for the years 1986-90 that revealed no mater­
ial overbilling of the government for unauthorized or inap­
propriate expenses.
Fiscal year 1991-92 also marked the moment when the 
university decisively narrowed the gap between overall 
expenses and income that had widened steadily during the 
five previous years. As illustrated by the graph that accompa­
nies this report, the shortfall between income and expenses 
grew from $11.6 million in 1988-89 to $14.0 million in 
1989-90, and $15 .8 million in 1990-91 before dropping 
sharply to $8.6 million in 1991-92. This movement toward finan-
cial balance is expected to continue in 1992-93. 
Also in 1991-92, the university's fund-raising from pri­
vate sources ( organized foundations, individual donors and 
private corporations) soared to an historic high of $28.5 mil­
lion in new gifts and pledges. This compared favorably with 
$9 .1 million in 1989-90 and $11.3 million in 1990-91. The 
dramatic increase in funds from private resources not only 
helped reduce the annual operating deficit, but enables the 
university to continue a multi-year process of expanding and 
strengthening its faculty. 
The university's record achievement of $28.5 million in 
new gifts and pledges during 1991-92: 
• resulted in cash receipts of $17. 9 million, an increase of 
$4.9 million, or 38 percent above the level of the previous
year;
• added $11. 7 million in current and future gifts to
strengthen our permanent endowment;
• enabled the university to plan continuing recruitment
and expansion of the research faculty by assuring $7 .6 mil­
lion in new gifts that will be received in the years immediat_e­
ly ahead, and will be applied to underwrite the university's
plans to expand its research faculty.
The university received several seven-figure leadership 
gifts which reflected an increased outreach to new 
friends led by members of the Board of Trustees, The 
Rockefeller University Council, and the Committee on 
Trust and Estate Gift Plans: 
• a $2 million challenge grant from a current trustee to
" 
members of the RU Council to double the private giving 
over the next two years by attaining a $10 million goal. 
During FY92, the first year of the challenge grant period, 
Council giving reached a record $5 million, representing a 
doubling from prior years; 
• a $1. 9 million challenge grant from The Carl J.
Herzog Foundation to raise endowment funds for the
Clinical Scholars Program at The Rockefeller University
Hospital. The grant provid½p $1 for every $2 contributed to
the endowment by other university friends;
• $3.6 million for arthritis and diabetes research from a
trust which paid a donor lifetime income and terminated on
her death, and a $1 million bequest in support of research
on schizophrenia. Both gifts were made possible by the
superb efforts of volunteers from the university's
Committee on Trust and Estate Gift Plans.
While dramatically stronger fund-raising has been 
essential to the university's financial turnaround, so, too, 
has been a determined effort to control and reduce expens­
es-to make do with less-in all facets of university opera­
tions, especially in administration and support services. 
Initiated by former President David Baltimore, and firmly 
continued and enforced by President Torsten Wiesel, .this 
"austerity" initiative asked everyone in the Rockefeller 
community to share in sacrifice by forgoing routine salary 
increases for academic year 1991-92, to live with the limita­
tions and frustrations of an employment freeze, and to 
engage cooperatively in office-by-office reviews that would 
rationally, carefully, but decisively downsize both the scale 
of functions, activities, and services, and the university's 
investment to support them. The result of this "austerity" 
initiative (as illustrated in the table accompanying this 
Statement of Expenditures and Resources Utilized 
Five Years Ended June 30, 1992 
(000's omitted) 
1988 1989 1990 1991 1992 
Expenditures 
Research and education $59,100 61,200 63,600 62,900 63,000 
Operations and maintenance of plant 12,300 14,100 14,600 14,900 14,300 
General administrative and institutional 10,400 12,000 12,800 13,700 12,300 
Auxiliary enterprises 11,100 12,400 14,700 15,900 14,900 
Debt service 1,200 1,200 1,300 1,300 1,300 
Capital expenditures 8,600 7,700 4,500 4,800 1,200 
Total Expenditures $102,700 108,600 111,500 113,500 107,000 
Resources Utilized 
Government grants and contracts $37,700 41,500 37,100 36,800 38,000 
Private gifts grants and contracts 19,500 18,300 20,100 18,700 17,400 
*Endowment income 24,200 24,500 25,000 25,100 24,400 
Auxiliary enterprises 8,500 9,600 12,200 13,800 14,300 
Other sources 3,100 3,100 3,100 3,300 4,300 
Total income $93,000 97,000 97,500 97,700 98,400 
Additional endowment resources 
needed to balance the budget 9,700 11,600 14,000 15,800 8,600 
Total Resources Utilized $102,700 108,600 111,500 113,500 107,000 
*Endowment income is defined as five percent of a three-year average market value 
The University uses annual audited statements. A copy for 1992 can be obtained from 
the Controller's Office, The Rockefeller University, 1230 York Avenue, New York, NY 10021. 
report) is that the university's total expenditures of $107 
million in 1991-92 dropped $6.5 million below the amount 
spent in 1990-91. 
Within this overall framework of cost limitation and 
reduction in 1991-92, the-university reduced: 
• the annual costs of general administration and institu­
tional management from $13.7 million to $12.3 million­
an absolute reduction of 10 percent;
• the annual costs of Facilities Management and
Planning from $14.9 million to $14.3 million-an absolute
reduction of 4 percent;
• the annual costs of auxili;ry service functions, particu­
larly residential housing and food services, from $15. 9 to
$14.9 million- an absolute reduction of 6.3%;
• expenditures for routine capital needs from $4.8 mil­
lion to $1.2 �illion-an absolute reduction of 75 percent.
As it faces the scientific challenges and opportunities of 
the future, the university has the continuing need to con­
tain and cut its overhead and support expenses, to constant- ' 
ly test concepts of improved or enhanced services against 
the discipline of "affordability," and to focus new adminis­
trative expenditures on support needs of the university 
community that simply must be met. In the new environ­
ment of scarcity, controlled management of resources is not 
merely desirable, but absolutely essential and inescapable. 
The university's leadership believes it met this demanding 
standard during 1991-92. It looks to the future with confi­
dence in .its capacity to protect and advance the university's 
scientific quality, while sustaining the recent gains in finan­
cial stability and strength. 
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The Rockefeller University 
Development Program 
New Gifts and Pledges 
Fiscal Years 1988-1992 
FY89 
Trustee 
Campaign 
(in millions) 
FY90 FY91 FY92 
Pledges and Gifts 
to Operating 
Support and Facilities 
July 1, 1991-June 30, 1992 
Foundations and 
Individuals 
Mr. & Mrs. Ralph E. Ablon 
AE Charitable Foundation 
Altman Foundation 
American Medico-Legal Foundation 
The Annenberg F51undation 
Anonymous 
Archbold Charitable Trust 
ARCS Foundation, Inc. 
The Vincent Astor Foundation 
Dr. Jesse Huntley Ausubel 
Mr. Mal L. Barasch 
Mr. Charles F. Barber 
The Theodore H. Barth Foundation 
Mr. & Mrs. Robert M. Bass 
Dr. & Mrs. Alexander G. Bearn 
Arnold and Mabel Beckman Foundation 
Dr. Paul Berg 
Mr. David Blech 
Jacob Bleibtreu Foundation Inc. 
The Sol Bloom Family Foundation, Inc. 
Mr. & Mrs. Steven Bloom 
Edith C. Blum Foundation 
The Bodman Foundation 
Mr. Frederick M. Bohen 
Botwinick-Wolfensohn Foundation, Inc. 
Mrs. Patricia S. Bradshaw 
Dr. Ronald Breslow 
BTW Fund of the NY Community Trust 
Llewellyn Burchell Charitable Trust 
Mr. Walter Burke 
The Louis Calder Foundation 
Mr. & Mrs. Paul A. Cameron 
Mr. Robert Cane 
Dr. Ronald E. Cape 
Carnegie Corporation of New York 
Mr. & Mrs. Robert Carswell 
Mary Flagler Cary Charitable Trust 
Mr. & Mrs. Lauriston Castleman 
Monique Weill Caulier Trust 
Mr. Guy J. Charlap 
Mr. & Mrs. Gustavos A. Cisneros 
Mrs. Helen Comando 
Mr. Daniel I. Cooper 
Council for Chemical Research Inc. 
The Cousins Foundation, Inc. 
Mrs. Susan L. Cullman 
Mr. Robert N. Davies 
Mr. Philippe de Fiers 
Ms. Kathryn M. Deane 
Mr. & Mrs. J. Richardson Dilworth 
The Dreitzer Foundation, Inc. 
Dr. Anne E. Dyson 
Mr. Harvey C. Dzodin 
Mrs. Marie N. Eising 
The Enzyme Club 
Ms. Eve Epstein 
Mrs. Angeles Espinosa Rugarcia 
Mr. C. Sims Farr 
Mr. & Mrs. Bernard Finkelstein 
Mr. & Mrs. Edward S. Finkelstein 
Forbes Foundation 
Mr. Alexander D. Forger 
Mr. Leonard Franklin 
Dr. & Mrs. Eugene Fubini 
Mr. Frederic J. Fuller 
Mr. Richard M. Furlaud 
Mr. & Mrs. Edward L. Gardner 
Dr. William C. Gibson 
Golden Family Foundation 
Herman Goldman Foundation 
Ms. Neva R. Goodwin 
Grand Street Boys· Foundation 
Hagedorn Fund 
Francena T. Harrison Foundation Trust 
Dr. & Mrs. Caryl P. Haskins 
Mr. Peter R. Hauspurg 
Mrs. Eleanor Marino Hawkins 
Mr. & Mrs. Norman M. Henderson 
Ms. Judith F. Hernstadt 
The Carl J. Herzog Foundation, Inc. 
Dr. Heisuke Hironaka 
Mr. & Mrs. Shinya Hirota 
Henrietta Hirsch Trust 
Mack J. Hirsch Trust 
The Irma T. Hirschi Trust 
Ms. Janet E. Hunt 
Ms. Katharina Jaeckh 
Jephson Educational Trust No. 2 
Robert Wood Johnson, Jr. 1962 
Charitable Trust 
Mrs. Helene L. Kaplan 
Mr. & Mrs. Joseph Kartiganer 
Mr. John J. Kindred 111 
Mrs. Nancy M. Kissinger 
The Esther A. and Joseph 
Klingenstein Fund, Inc. 
Or. Antonie T. Knoppers 
Mr. Pedro-Pablo Kuczynski 
Eugene M. Lang Foundation 
The Jacob and Valeria 
Langeloth Foundation 
Dr. Philip Leder 
Ors. Joshua & Marguerite Lederberg 
Dolores Z. Liebmann Trust 
Mr. & Mrs. Edmund W. Littlefield 
Mr. Alexander MacN. Luke 
Mr. Ira H. Lustgarten 
Mr. & Mrs. John D. Macomber 
Dr. Ernest Mario 
Lucille P. Markey Charitable Trust 
Donald B. and Catherine C. 
Marron Foundation 
Abby R. Mauze Charitable Trust 
William & Helen Mazer Foundation 
Mrs. Carlyn S. McCaffrey 
Dr. & Mrs. Maclyn McCarty 
Mr. Thomas K. Mccaughey 
Mr. John J. McDermott 
The McIntosh Foundation 
Mrs. Esther H. Miller 
Estate of Fay Minkowich 
Edward S. Moore Foundation, Inc. 
Mr. Jeffrey-Paul Nash 
Samuel 1. Newhouse Foundation Inc. 
Mr. Albert L. Nickerson Mr. Julius Wile Hoechst Celanese Corporation The Carl J. Herzog Foundation, Inc. 
Mr. Phil R. North Mr. Allan Wittman Suzanne T. Karpas & Irving D. Karpas, Mr. Leon Hess 
Mr. & Mrs. Donal C. O'Brien, Jr. Ms. Diane Wolf Jr. Foundation, Inc. Hess Foundation, Inc. 
Dr. & Mrs. Ralph A. O'Connell Adm. Elmo R. Zumwalt Eugene M. Lang Foundation Hormone Research Foundation 
Mr. John J. O'Grady Ill Dorothea Leonhardt Fund of IBM Corporation 
Abby and George O'Neill Trust Communities Foundation of Texas Sumi L. Koide Memorial Fund 
Mr. Milton Okin Corporations Richard Lounsbery Foundation Lakeview Fund, Inc. 
Ms. Dorinda J. Oliver Mr. John D. Macomber The Leonhardt Foundation, Inc. 
The Pack Foundation for and Corporate Edward Mallinckrodt, Jr. Foundation The Dorothea L. Leonhardt 
Medical Research Foundations Lucille P. Markey Charitable Trust Foundation, Inc. 
Mr. & Mrs. Bernard G. Palitz 
Alimansky Capital Group Inc. 
William & Helen Mazer Foundation Dorothea Leonhardt Fund of 
The Papamarkou Foundation The Merck Company Foundation Communities Foundation of Texas 
Park Avenue Charitable Fund Bristol-Myers Squibb Company Ogden Management Services, Inc. Frederick H. Leonhardt Fund of 
Mr. Russell P. Pennoyer Bristol-Myers Squibb Foundation. Inc. The Pew Charitable Trusts The New York Community Trust 
The Perkin Fund Carnegie Council on Ethics/lnt'I Affairs The Carl and Lily Marjorie Lewisohn 
The Honorable & Mrs. Carl Celgene Corporation Pforzheimer Foundation Dolores Z. Liebmann Trust 
H. Pforzheimer, Jr. Chanel, Inc. Charles H. Revson Foundation Burton A. Maddock Trust 
Ms. Beatrice Philippe Charmer Industries, Inc. Mr. David Rockefeller, Jr. Lucille P. Markey Charitable Trust 
The Howard Phipps Foundation Consolidated Edison Company Dr. Richard G. Rockefeller Estate of Abby R. Mauze 
Mr. John H. Pinto of New York Dr. George Rosenkranz The Andrew W. Mellon Foundation 
Anne & George Popkin Foundation Inc. E. I. du Pont de Nemours & Company Lawrence Ruben 198J Charitable Trust Richard King Mellon Foundation 
Dr. Frank Press Hoffmann-LaRoche Inc. The Richard and Edna Salomon The Merck Company Foundation 
Mr. Andrew W. Regan The IFF Foundation Inc. Foundation. Inc. The Andre and Bella Meyer 
Gustave A. Reh, Jr. Unitrust Industrias Villares, S.A. Mr. Morris M. Schrier Foundation, Inc. 
Harold and Beatrice ITT Corporation Mr. R. L. Van Valer Estate of Stanford Moore 
Renfield Foundation, Inc. Merck & Co., Inc. Mr. John C. Whitehead Mr. Gunnar W. E. Nicholson 
Mrs. Oscar de la Renta Pfizer Foundation, Inc. The Norman and Rosita Ogden Management Services, Inc. 
Estate of Joseph W. Rintelen The Rockefeller Group Winston Foundation, Inc. Mr. & Mrs. George D. O'Neill 
Mr. & Mrs. David Rockefeller Charles Sadek Import Co., Inc. The Rapid-American Foundation for the 
Mr. Mark F. Rockefeller Spaulding & Evenflo Companies, Inc. Benefit of The Rockefeller University 
Dr. Richard G. Rockefeller & Volvo Harold and Beatrice Renfield 
Ms. Nancy Anderson The Whitney Group Gifts to Endowment Foundation, Inc. 
Mr. & Mrs. Theodore C. Rogers The Wilkerson Group, Inc. Mr. Ralph E. Ablon R. J. Reynolds Industries, Inc. 
Frederick P. and Sandra P. Stanley Abrams Memorial Fund Mr. David Rockefeller 
Rose Foundation Allen & Company Rockefeller Brothers Fund 
Mrs. Doris L. Rosenberg Payments Received The Diana L. and Arthur G. Mr. Frederick P. Rose 
Altschul Fund Mr. John M. Rudey during FY92 on pledges Mr. Jack Rudin 
Mr. Oscar M. Ruebhausen The Annenberg Foundation Raymond and Beverly Sackler 
Mr. Richard E. Salomon made in previous years Anonymous Foundation, Inc. 
The Richard and Edna Salomon Mr. Ralph E. Ablon 
The Leslie Arps Cancer Fund Mr. Morris M. Schrier 
Foundation, Inc. The Annenberg Foundation 
The Vincent Astor Foundation Mr. Gunther K. Schwerin 
Mr. Sanford J. Schlesinger ARCS Foundation. Inc. 
Arnold and Mabel Beckman Foundation Spaulding & Evenflo Companies, Inc. 
Mr. Sidney H. Schneck Rose M. Badgeley Residuary 
Alumnae Association of the Squibb Corporation 
Estate of Elise M. Schuppe Charitable Trust 
Bellevue School of Nursing William H. Stein Fund 
The Edith M. Schweckendieck The Becton Dickinson Foundation 
Mr. David Blech Surdna Foundation 
Charitable Trust Mr. Curtis L. Blake 
Gladys Brooks Foundation Toyota Motor Corporation 
Mr. Charles Scribner, Jr. Botwinick-Wolfensohn Foundation, Inc. 
Estate of Beatrice Bruyn Estate of John Manning Van Heusen 
Dr. & Mrs. Frederick Seitz Bristol-Myers Squibb Company 
Cancer Research Institute DeWitt Wallace Fund #3 of 
Mr. & Mrs. Jerome A. Siegel The Brookdale Foundation 
Chevron U.S.A. Inc. Community Funds, Inc. 
Herbert and Nell Singer Dr. Ronald E. Cape 
Dr. & Mrs. Purnell W. Choppin Miriam and Ira D. Wallach Foundation 
Foundation, Inc. The Commonwealth Fund 
Mrs. Irma L. Croll Dr. & Mrs. Jerry A. Weisbach 
The Skin Disease Society, Inc. Mr. Disque D. Deane 
The Irma and Abram Croll Estate of James R. Withrow, Jr. 
Alfred P. Sloan Foundation Ira W. DeCamp Foundation 
Foundation. Inc. Lester Wolfe Charitable Trust 
Seth Sprague Educational & Elf Aquitaine. Inc. 
Dr. Bernard S. Davison 
Charitable Foundation Francis Florio Fund of 
Mr. & Mrs. J. Richardson Dilworth 
Mr. Stephen Stamas The New York Community Trust 
The Camille and Henry Dreyfus 
In-kind Donations Estate of Robert Stevens Mr. Richard M. Furlaud Foundation, Inc. 
Mr. Robert G. Stone Ms. Neva R. Goodwin 
Ors. Julian & Elizabeth Eisenstein Individuals 
Mr. Frederick A. Terry, Jr. Mrs. Eileen R. Growald 
The Charles Engelhard Foundation Mr. Gunther K. Schwerin 
Dr. P. Roy Vagelos Mary W. Harriman Foundation 
Sherman Fairchild Foundation, Inc. 
Mr. John H. Vogel Ms. Maxine Harrison 
Dr. Jack Fishman Corporations 
Watcha Fund Lita Annenberg Hazen Charitable Trust 
Mrs. Rita R. Fraad Harris Corporation 
The Sidney J. Weinberg, Jr. Foundation Mrs. Marian S. Heiskell 
Estate of Ernst Friedheim Zetaco, Inc, 
The Isak & Rose Weinman The Carl J. Herzog Foundation, Inc. 
Dr. Eugene Garfield 
Foundation, Inc. Mr. William R. Hewlett 
Mr. Clar�nce H. Gifford, Jr. 
Nina W. Werblow Charitable Trust The Irma T. Hirschi Trust 
Estate of Henry A. Gilbert 
Mr. Edwin C. Whitehead Gulf Oil Foundation 
The Whitehead Foundation Mr. & Mrs. Patrick E. Haggerty 
Ms. Maxine Harrison 
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Endnotes 
Factors Favorable for the· 
Continued Advance of Science 
Dr. Frederick Seitz, president emeritus 
of The Rockefeller University and for­
mer president of the National Academy 
of Sciences, considers the future of scien­
tific research in the following excerpt 
from his new book,  The Science 
Matrix: The Journey, Travails, 
Triumphs (New York: Springer­
Verlag, 1992). 
INNATE CURIOSITY 
The most important factor assuring 
the continued advance of basic sci­
ence lies in the combination of 
earnest curiosity regarding nature 
and the desire for self-expression 
that resides in many talented and 
imaginative young people-deeply 
ingrained human traits. These traits 
have been instrumental in the evolu­
tion of science from its beginning. 
Indeed, such curiosity can continue 
unabated for a lifetime in the well­
initiated, not least in the profession­
al scientist, in spite of varying levels 
of creativity. 
Alongside this we now possess, as 
a result of nearly five centuries of 
experience, knowledge of the combi­
nation of experiment, logical analy­
sis, speculative theory and institu­
tional structure needed to form a 
solid platform for the advance of sci­
ence. None of these guarantee the 
appearance of that flash of inspired 
insight from a great mind that is 
occasionally necessary to introduce a 
major new evolutionary concept 1n 
some field. In this respect we will 
apparently always depend upon the 
arrival of the appropr�ate level of 
genius at the active scene during 
special periods in the development 
of a field. Fortunately, such preg­
nant moments seem to attract the 
appropriately gifted sooner rather 
than later. One can only hope that 
this will continue to be the case 
indefinitely. 
PRACTICAL NEED, 
NATIONAL PRIDE 
Also on the positive side, it seems 
clear at present that under normal 
circumstances the advanced industri­
al societies will have a continuous 
need for the further infusion of new 
scientific knowledge for several good 
reasons. Some of the need will arise 
from a basic interest in the revela­
tions of science, some from its edu­
cational value, and some from issues 
such as the improvement of public 
health, industrial competitiveness, 
defense and what might be called 
replacement technology-such as 
finding substitutes for materials in 
dwindling supply. 
Then, too, there is national 
pride, which has been a significant 
motivating factor in the past and 
which will probably be significant as 
long as we have a diversity of ethnic 
and cultural groups on an interna­
tional scale .... 
by Frederick Seitz 
GLOBAL ISSUES 
Finally, it is likely that there will be 
global problems that require the 
encouragement of reasonably coor­
dinated basic as well as applied 
research ;t many centers on a world­
wide basis. Issues such as concern 
about the global environment or 
problems related to health such as 
cancer and acquired immune defi­
ciency syndrome (AIDS), not to 
mention as yet unforeseen but 
inevitable pandemics, will require 
enlisting scientists from many insti­
tutions who are prepared to work at 
the most basic levels of current 
understanding. It is, in fact, remark­
able that the worldwide epidemic of 
AIDS occurs just when our ability to 
achieve understanding of the disease 
is possible and when detailed scien­
tific investigations can be carried out 
internationally in a concerted way. 
This is undoubtedly not the last 
time that the international scientific 
community will be called upon in a 
similar manner. 
Then too, there will be less life­
threatening scientific adventures 
which can benefit from international 
cooperation. The coordinated 
research programs in the antarctic 
provide one present-day example. 
The development of very high reso­
lution astronomical observatories on 
the moon, including extended arrays 
which might observe planets on 
neighboring stars, could provide 
such an international adventure in 
the near future. 
Reprinted with permission from Springer-Verlag 
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